Navigation Links
Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
Date:11/2/2009

PRINCETON, N.J., Nov. 2 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Jeffrey Trotter has joined the Company as Executive Vice President, Phase IV Development. In his role, he will provide leadership for the Company's Phase IV operations and its global expansion.

"We are very pleased to have Jeff Trotter join PharmaNet," commented Jeffrey P. McMullen, president and chief executive officer. "His depth of experience and pioneering approaches to patient registries, health economics and outcomes research will enable us to expand our services to clients seeking to undertake the full range of peri-approval research programs."

Mr. McMullen continued, "Phase IV services continue to be a growth opportunity for PharmaNet. I am confident we can strengthen our presence to become the definitive choice for research excellence in this critical and rapidly changing field."

As an entrepreneur, researcher, consultant and industry leader, Jeffrey Trotter has been an innovator in the evolving outcomes research community, most recently providing strategic and operational direction to pharmaceutical and device companies on the importance of 'real world' clinical research, observational studies and patient registries. Mr. Trotter was founder and president of Ovation Research Group, one of the leading independent research and consulting organizations providing health economics and outcomes research for pharmaceutical and medical device companies. Ovation became known worldwide for its industry-leading perspectives on patient registries, clinical studies fulfilling a broad continuum of needs ranging from product commercialization to safety surveillance and risk management. Having sold Ovation, Jeff joins PharmaNet Development Group from his independent consultancy, J. Trotter Research and Consulting.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    Email: ahess@pharmanet.com

SOURCE PharmaNet Development Group


'/>"/>
SOURCE PharmaNet Development Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
2. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
3. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
4. Marsha Fanucci Joins Ironwood Board of Directors
5. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
6. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
7. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
8. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
9. UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
10. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
11. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):